AB680
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AB680, covering 2024-05-24 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies [Phase 1]